Volume 71, Issue 4
Original Article

Prevalence of human xenotropic murine leukemia virus‐related gammaretrovirus (XMRV) in dutch prostate cancer patients

Gerald W. Verhaegh

Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands

Search for more papers by this author
Arjan S. de Jong

Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Nijmegen Centre for Infection, Inflammation and Immunity, Nijmegen, The Netherlands

Search for more papers by this author
Frank P. Smit

NovioGendix B.V., Nijmegen, The Netherlands

Search for more papers by this author
Sander A. Jannink

NovioGendix B.V., Nijmegen, The Netherlands

Search for more papers by this author
Willem J.G. Melchers

Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands

Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Nijmegen Centre for Infection, Inflammation and Immunity, Nijmegen, The Netherlands

Search for more papers by this author
Jack A. Schalken

Corresponding Author

E-mail address: j.schalken@uro.umcn.nl

Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands

Department of Urology and Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.Search for more papers by this author
First published: 28 September 2010
Citations: 33

There are no conflicts of interest.

Abstract

BACKGROUND

The occurrence of the retrovirus xenotropic murine leukemia virus (MLV)‐related virus (XMRV) has been reported in prostate tissue of patients with prostate cancer (PrCa). Considering the potential great medical and social relevance of this discovery, we investigated whether this finding could be confirmed in an independent group of Dutch sporadic PrCa cases.

METHODS

We investigated the occurrence of XMRV in fresh‐frozen PrCa specimens of 74 PrCa patients from The Netherlands. Total RNA and DNA were isolated, subjected to cDNA synthesis, and analyzed by real‐time PCR targeting conserved XMRV sequences.

RESULTS

Spiking experiments showed that we were able to detect at least 10 copies of XMRV sequences in 100,000 cells by real‐time PCR, demonstrating high sensitivity of the assay. XMRV sequences were detected in 3 out of 74 (i.e., 4%) PrCa specimens. The number of XMRV containing cells was extremely low (1 in 600–7,000 cells). This was corroborated by the fact that XMRV could not be detected in consecutive tissue sections of the initial XMRV‐positive cases.

CONCLUSIONS

XMRV was rarely detected, and at extremely low levels, in sporadic PrCa samples from Dutch patients. When XMRV would play a causal role in prostate carcinogenesis, integration of the provirus could be expected to be present in, at least, a proportion of tumor cells. Therefore, our data do not support the claim that there is an association between XMRV infection and PrCa in Dutch PrCa patients. Prostate 77:415–420, 2011. © 2010 Wiley‐Liss, Inc.

Number of times cited according to CrossRef: 33

  • Xenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood Supply, Clinical Microbiology Reviews, 10.1128/CMR.00086-15, 29, 4, (749-757), (2016).
  • XMRV: Emerging Human Infection or False Alarm, Global Virology I - Identifying and Investigating Viral Diseases, 10.1007/978-1-4939-2410-3, (561-574), (2015).
  • No association between XMRV or related gammaretroviruses in Australian prostate cancer patients, Virology Journal, 10.1186/1743-422X-10-20, 10, 1, (20), (2013).
  • Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review, Urologic Oncology: Seminars and Original Investigations, 10.1016/j.urolonc.2012.01.013, 31, 7, (951-965), (2013).
  • No Detection of Xenotropic Murine Leukemia Virus-Related Viruses in Prostate Cancer in Sanandaj, West of Iran, Asian Pacific Journal of Cancer Prevention, 10.7314/APJCP.2013.14.11.6929, 14, 11, (6929-6933), (2013).
  • Inflammation and prostate carcinogenesis, International Journal of Urology, 10.1111/j.1442-2042.2012.03101.x, 20, 2, (150-160), (2012).
  • Short Communication: RNASEL Alleles and Susceptibility to Infection by Human Retroviruses and Hepatitis Viruses, AIDS Research and Human Retroviruses, 10.1089/aid.2012.0014, 28, 10, (1259-1261), (2012).
  • Development of sensitive single-round pol or env RT-PCR assays to screen for XMRV in multiple sample types, Journal of Virological Methods, 10.1016/j.jviromet.2011.10.010, 179, 1, (127-134), (2012).
  • Prevalence of Xenotropic Murine Leukemia Virus-Related Virus Infection in Different Risk Populations in Spain, AIDS Research and Human Retroviruses, 10.1089/aid.2011.0149, 28, 9, (1089-1094), (2012).
  • Recombinant origin, contamination, and de-discovery of XMRV, Current Opinion in Virology, 10.1016/j.coviro.2012.06.009, 2, 4, (499-507), (2012).
  • XMRV and prostate cancer—a 'final' perspective, Nature Reviews Urology, 10.1038/nrurol.2011.225, 9, 2, (111-118), (2012).
  • Lack of evidence for a role of xenotropic murine leukemia virus-related virus in the pathogenesis of prostate cancer and/or chronic fatigue syndrome, Virus Research, 10.1016/j.virusres.2012.04.004, 167, 1, (1-7), (2012).
  • XMRV Induces Cell Migration, Cytokine Expression and Tumor Angiogenesis: Are 22Rv1 Cells a Suitable Prostate Cancer Model?, PLoS ONE, 10.1371/journal.pone.0042321, 7, 7, (e42321), (2012).
  • Absence of XMRV and Closely Related Viruses in Primary Prostate Cancer Tissues Used to Derive the XMRV-Infected Cell Line 22Rv1, PLoS ONE, 10.1371/journal.pone.0036072, 7, 5, (e36072), (2012).
  • Susceptibility of Human Lymphoid Tissue Cultured ex vivo to Xenotropic Murine Leukemia Virus-Related Virus (XMRV) Infection, PLoS ONE, 10.1371/journal.pone.0037415, 7, 5, (e37415), (2012).
  • Absence of XMRV in Peripheral Blood Mononuclear Cells of ARV-Treatment Naïve HIV-1 Infected and HIV-1/HCV Coinfected Individuals and Blood Donors, PLoS ONE, 10.1371/journal.pone.0031398, 7, 2, (e31398), (2012).
  • Seroprevalence of xenotropic murine leukemia virus–related virus in normal and retrovirus‐infected blood donors, Transfusion, 10.1111/j.1537-2995.2011.03395.x, 52, 2, (307-316), (2011).
  • Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase, Nucleic Acids Research, 10.1093/nar/gkr694, 40, 1, (345-359), (2011).
  • No evidence for a role of xenotropic murine leukaemia virus-related virus and BK virus in prostate cancer of German patients, Medical Microbiology and Immunology, 10.1007/s00430-011-0215-0, 201, 2, (245-248), (2011).
  • In Vitro Assembly of Virus-Like Particles of a Gammaretrovirus, the Murine Leukemia Virus XMRV, Journal of Virology, 10.1128/JVI.05564-11, 86, 3, (1297-1306), (2011).
  • Characterization, Mapping, and Distribution of the Two XMRV Parental Proviruses, Journal of Virology, 10.1128/JVI.06022-11, 86, 1, (328-338), (2011).
  • XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27Kip1, The Prostate, 10.1002/pros.21491, 72, 8, (886-897), (2011).
  • Xenotropic murine leukaemia virus‐related virus is not found in peripheral blood cells from treatment‐naive human immunodeficiency virus‐positive patients, Clinical Microbiology and Infection, 10.1111/j.1469-0691.2011.03580.x, 18, 2, (184-188), (2011).
  • Absence of xenotropic murine leukemia virus–related virus in blood donors in China, Transfusion, 10.1111/j.1537-2995.2011.03267.x, 52, 2, (326-331), (2011).
  • No evidence of XMRV in prostate cancer cohorts in the Midwestern United States, Retrovirology, 10.1186/1742-4690-8-23, 8, 1, (23), (2011).
  • False negative results from using common PCR reagents, BMC Research Notes, 10.1186/1756-0500-4-457, 4, 1, (2011).
  • XMRV Discovery and Prostate Cancer-Related Research, Advances in Virology, 10.1155/2011/432837, 2011, (1-10), (2011).
  • XMRV, prostate cancer and chronic fatigue syndrome, British Medical Bulletin, 10.1093/bmb/ldr010, 98, 1, (61-74), (2011).
  • Phylogeny-Directed Search for Murine Leukemia Virus-Like Retroviruses in Vertebrate Genomes and in Patients Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Prostate Cancer, Advances in Virology, 10.1155/2011/341294, 2011, (1-20), (2011).
  • Is XMRV a causal virus for prostate cancer?, Asian Journal of Andrology, 10.1038/aja.2011.32, 13, 5, (698-701), (2011).
  • Detection of Murine Leukemia Virus or Mouse DNA in Commercial RT-PCR Reagents and Human DNAs, PLoS ONE, 10.1371/journal.pone.0029050, 6, 12, (e29050), (2011).
  • No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe, PLoS ONE, 10.1371/journal.pone.0025592, 6, 10, (e25592), (2011).
  • Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome, Reviews in Medical Virology, 10.1002/rmv.673, 21, 1, (3-17), (2010).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.